Issue 1: How to formulate policy and guidance for cost-sharing schemes (INO, MMR, NEP, THA).
a) WHO should provide advice on policy as well as law and/or regulations for cost-sharing scheme(s) to countries that decide to implement this type of programme.
b) Country situation studies should be made to formulate suitable policy and guidance for cost-sharing schemes.
Issue 2: How to control drug prices on the open market (THA).
a) Government should formulate appropriate drug pricing policy to ensure access to essential drugs.
b) Price lists should be displayed in medical shops as should information for the general public about the price of the drugs promoted.
c) The use of generic drugs should be promoted.
d) Some countries may consider providing incentives for local drug manufacturers to reduce the prices of essential drugs.
Issue 3: How to re-supply health services and get quality drugs at the lowest possible prices (MMR, NEP).
a) There should be a good management information system.
b) There should be good inventory control and transportation systems.
c) Producers and suppliers should have to be prequalified.
d) There should be competitive group bidding and bargaining among prequalified suppliers.